Pneumonia Testing Market: Global Industry Analysis and Forecast (2024-2030)

The Pneumonia Testing Market size was valued at USD 2.11 Bn. in 2023 and the total Pneumonia Treatment revenue is expected to grow at a CAGR of 7.6% from 2024 to 2030, reaching nearly USD 3.5 Bn. in 2030.

Pneumonia Testing Market Overview:

The Pneumonia is an inflammatory condition of the lung primarily affecting the small air sacs known as alveoli. Pneumonia is usually caused by infection with viruses or bacteria, and less commonly by other microorganisms. Identifying the responsible pathogen is difficult. Diagnosis is often based on symptoms and physical examination. Demand for pneumonia testing is rising owing to the growth in the incidence of respiratory infections, particularly in elderly and immunocompromised populations. Additionally, the rise in healthcare expenditure, the presence of advanced healthcare infrastructure, and the availability of reimbursements are anticipated to create lucrative opportunities in the industry. Numerous treatment options such as oseltamivir and acyclovir among others are used to treat the antiviral infection. Likewise, the drugs help reduce the severity of the flu virus spreading into the body, further enhancing the market progression. Thus, more and more consumption of antiviral drugs acts as a major driver of growth in the global pneumonia therapeutics market. The U.S. Food and Drug Administration approved Xacduro (sulbactam for injection; sulbactam for injection), a new treatment for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii-calcoaceticus complex, for patients 18 years of age and older. On World Pneumonia Day, FIRS calls on governments and other stakeholders to take urgent action to tackle pneumonia by: 1. Strengthening health systems capacity. 2. Ensuring that all children and vulnerable adults receive effective pneumonia vaccines. 3. Reducing air pollution and exposure to air pollutants and promoting good nutrition, hygiene practices, and smoking cessation to reduce the risk of pneumonia. 4. Raising awareness and knowledge about pneumonia prevention and treatment. 5. Improving access to antibiotics, pulse oximetry, and oxygen therapy. 6. Encouraging funders to invest in pneumonia research and services and supporting research to implement pneumonia prevention and treatment interventions.Pneumonia Testing MarketTo know about the Research Methodology:-Request Free Sample Report

Pneumonia Testing Market Dynamic:

Driving Factors and Growth Opportunities in the Community-Acquired Pneumonia Treatment Market The rising prevalence of pneumonia and concerns associated with pneumonia mortality are notably driving the market research growth. Driving the demand for pneumonia testing helps in identifying the causative agent of the disease and providing appropriate treatment. The elderly population is more susceptible to pneumonia and other respiratory infections. Many governmental organizations throughout the world are investing in research & development operations to produce new antibiotics, as well as measures to encourage effective community-acquired bacterial pneumonia treatment diagnosis and treatment. The activities and financing are likely to propel the growth of the global community-acquired bacterial pneumonia treatment market. The burgeoning healthcare industry represents one of the key factors driving the market. There is an increased need for accurate testing procedures because elderly people are more vulnerable to respiratory infections, including pneumonia. Moreover, the demographic factor highlights early detection and the market’s responsibility to meet the unique healthcare needs of the aging population. The Rise of Point-of-Care Diagnostic Methods The development of new and more sensitive and specific testing methods is augmenting the global pneumonia testing business. There is a rise in the utilization of point-of-care (POC) testing to detect pneumonia on account of its higher efficiency and rapid and accurate test results. The advanced multiplex PCR (mPCR) based platform for diagnosing pneumonia offers higher detection efficiency, thereby reducing cost and time. The DNA or RNA replication of very minute microorganisms also does not require live microorganisms and is thus not affected by the prior usage of antibiotics. Therefore with the high prevalence of chronic diseases in a large customer base adopting cost-effective and immediate diagnostic tests, is propelling point-of-care testing. The advantages of the POC test to render rapid and accurate results help in promoting patient-centred healthcare at bedside settings which further results in the adoption of point-of-care testing and thereby promoting the growth of the pneumonia testing market.

Pneumonia Testing Market1Challenges Hindering Growth to Pneumonia Diagnostics Market

The pricing pressure owing to competition and difficulty in diagnosing hamper the growth of the pneumonia diagnostics market through the forecast period. One of the most critical factors restraining the market growth is the widespread utilization of chest X-rays as an essential tool for pneumonia detection. Similarly, low healthcare awareness across lower economies along with inadequate reimbursement policies is emerging as a significant impediment to the development of the pneumonia diagnostics market. Cultures, the traditional method, are still mostly used to detect pneumonia-causative organisms, which hampers the growth of pneumonia Treatment.

Pneumonia Testing Market Segmentation:

Based on End Users, Pneumonia Testing is mostly used in hospitals and clinics and contributes to the largest market share of 60 %. The rise in adoption of the testing for pneumonia is driving the market growth. Pneumonia is one of the leading causes of mortality and hospitalization among US adults. Hospitalizations for pneumonia have been on the rise, and that trend is particularly true among elderly adults (aged ≥65 years). The elderly are thought to be particularly susceptible to pneumonia requiring hospitalization because of the higher prevalence of comorbid diseases, such as chronic cardiac and pulmonary disease or diabetes mellitus, in that population.  There were around 2,500 hospitals in Colombia, 8240 hospitals in Japan, and 6,120 hospitals in the United States in 2023.

Pneumonia Testing Market2Pneumonia Testing Market Regional Insight:

North America is the largest region with a market share of 38% for the pneumonia testing market owing to the growing burden of pneumonia infection and increasing product approvals. North America has a well-established medical infrastructure, with advanced laboratory facilities and highly trained medical professionals. It also has strong regulatory support for medical technology, including pneumonia testing. Growth in the USA pneumonia diagnostics market is driven by the rising prevalence of pneumonia, increasing diagnostic screening rates owing to high levels of awareness among people, and the presence of leading manufacturers. There has been a significant rise in the cases of pneumonia and pneumonia-related deaths across the USA which has necessitated the adoption of pneumonia diagnostics. One data source is the National Syndromic Surveillance Program (NSSP), which monitors anonymized daily visit data from around 78% of emergency departments in the United States The diagnosis of pneumonia in children, along with other respiratory illnesses, increases every year during the fall and winter months in the United States. As of November 25, 2023, NSSP data indicated that the weekly percent of emergency department visits with diagnosed pneumonia was 1. 1.7% for children aged 0–1 years, 2. 2.4% for children aged 2–4 years, and 3. 1.5% for children aged 5–17 years. About 1 million adults in the US seek care in a hospital due to pneumonia every year and 50,000 die from Pneumonia. Then the age extremes, it is always a threat. Half of all non-immunocompromised adults hospitalized for severe pneumonia in the US are younger adults (18-57 years of age).

Pneumonia Testing Market3Competitive Landscape:

In August 2023, Science and medical technology firm Danaher announced that agreed to acquire Abcam, a Cambridge, and U.K.-based supplier of antibodies, reagents, biomarkers, and assays. Under the agreement, Danaher will acquire all outstanding Abcam shares for $24 per share in cash, with a total enterprise value of approximately $5.7 billion, including Abcam's assumed debts and net of acquired cash. In October 2023, Merk & Co. acquired ImaBIotech. ImaBIotech’s focus is on developing new antibiotics for multi-drug-resistant bacterial infections. The acquisition signifies continued, which is crucial for treating bacterial pneumonia.

Pneumonia Testing Market Scope: Inquire before buying

Global Pneumonia Testing Market
Report Coverage Details
Base Year: 2023 Forecast Period: 2024-2030
Historical Data: 2018 to 2023 Market Size in 2023: US $ 2.11 Bn.
Forecast Period 2024 to 2030 CAGR: 7.6% Market Size in 2030: US $ 3.5 Bn.
Segments Covered: By Type Streptococcus Legionella Chlamydophila Viral Pneumonia Mycoplasma Pneumonia
By Methods Molecular Diagnostics Point of Care Testing Immunodiagnostics
By End Users Hospitals & Clinics Diagnostic Laboratories Homecare

Pneumonia Testing Market, by Region:-

North America (United States, Canada, and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan, and the Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria, and the Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Key players of the Pneumonia Testing Industry:

1. Thermo Fisher Scientific Inc. 2. Abbott Laboratories 3. F-Hoffmann la Roche Ltd. 4. Hologic Inc. 5. BioMerieux 6. Becton 7. Dickenson and Company 8. Bio-Rad Laboratories Inc. 9. Meridian Biosciences 10. Quest Diagnostics, and Quidel. 11. AdvanDx 12. Beckman Coulter 13. Cepheid 14. Concile 15. Diamedix 16. DiaSorin 17. Fast-track Diagnostics 18. SeraCare 19. Trinity Biotech

Frequently Asked Questions:

1] What segments are covered in the Pneumonia Testing Market report? Ans. The segments covered in the Pneumonia Testing Market report are based on Type, Methods, and End Users. 2] Which region is expected to hold the highest share in the Pneumonia Testing Market? Ans. The North American region is expected to hold the highest share of the Pneumonia Testing Market. 3] What is the market size of the Pneumonia Testing Market by 2030? Ans. The market size of the Pneumonia Testing Market by 2030 will be $ 3.5 Billion. 4] What is the forecast period for the Pneumonia Testing Market? Ans. The Forecast period for the Pneumonia Testing Market is 2024- 2030.
1. Pneumonia Testing Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Pneumonia Testing Market: Dynamics 2.1. Pneumonia Testing Market Trends by Region 2.1.1. North America Pneumonia Testing Market Trends 2.1.2. Europe Pneumonia Testing Market Trends 2.1.3. Asia Pacific Pneumonia Testing Market Trends 2.1.4. Middle East and Africa Pneumonia Testing Market Trends 2.1.5. South America Pneumonia Testing Market Trends 2.2. Pneumonia Testing Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Pneumonia Testing Market Drivers 2.2.1.2. North America Pneumonia Testing Market Restraints 2.2.1.3. North America Pneumonia Testing Market Opportunities 2.2.1.4. North America Pneumonia Testing Market Challenges 2.2.2. Europe 2.2.2.1. Europe Pneumonia Testing Market Drivers 2.2.2.2. Europe Pneumonia Testing Market Restraints 2.2.2.3. Europe Pneumonia Testing Market Opportunities 2.2.2.4. Europe Pneumonia Testing Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Pneumonia Testing Market Drivers 2.2.3.2. Asia Pacific Pneumonia Testing Market Restraints 2.2.3.3. Asia Pacific Pneumonia Testing Market Opportunities 2.2.3.4. Asia Pacific Pneumonia Testing Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Pneumonia Testing Market Drivers 2.2.4.2. Middle East and Africa Pneumonia Testing Market Restraints 2.2.4.3. Middle East and Africa Pneumonia Testing Market Opportunities 2.2.4.4. Middle East and Africa Pneumonia Testing Market Challenges 2.2.5. South America 2.2.5.1. South America Pneumonia Testing Market Drivers 2.2.5.2. South America Pneumonia Testing Market Restraints 2.2.5.3. South America Pneumonia Testing Market Opportunities 2.2.5.4. South America Pneumonia Testing Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Regulatory Landscape by Region 2.5.1. North America 2.5.2. Europe 2.5.3. Asia Pacific 2.5.4. Middle East and Africa 2.5.5. South America 2.6. Pneumonia Testing Clinical Trial Analysis for Pneumonia Testing 2.7. Key Opinion Leader Analysis For the Pneumonia Testing Industry 2.8. Analysis of Government Schemes and Initiatives For the Pneumonia Testing Industry 3. Pneumonia Testing Market: Global Market Size and Forecast by Segmentation (by Value in USD Billion) (2023-2030) 3.1. Pneumonia Testing Market Size and Forecast, by Type (2023-2030) 3.1.1. Streptococcus 3.1.2. Legionella 3.1.3. Chlamydophila 3.1.4. Viral Pneumonia 3.1.5. Mycoplasma Pneumonia 3.2. Pneumonia Testing Market Size and Forecast, by Method(2023-2030) 3.2.1. Molecular Diagnostics 3.2.2. Point of Care Testing 3.2.3. Immunodiagnostics 3.3. Pneumonia Testing Market Size and Forecast, by End- User (2023-2030) 3.3.1. Hospitals & Clinics 3.3.2. Diagnostics Laboratories 3.3.3. Homecare 3.4. Pneumonia Testing Market Size and Forecast, Region (2023-2030) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Pneumonia Testing Market Size and Forecast by Segmentation (by Value in USD Billion) (2023-2030) 4.1. North America Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 4.1.1. Streptococcus 4.1.2. Legionella 4.1.3. Chlamydophila 4.1.4. Viral Pneumonia 4.1.5. Mycoplasma Pneumonia 4.2. North America Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 4.2.1. Molecular Diagnostics 4.2.2. Point of Care Testing 4.2.3. Immunodiagnostics 4.3. Pneumonia Testing Market Size and Forecast, by End- User (2023-2030) 4.3.1. Hospitals & Clinics 4.3.2. Diagnostics Laboratories 4.3.3. Homecare 4.4. North America Pneumonia Testing Market Size and Forecast, by Country (2023-2030) 4.4.1. United States 4.4.1.1. United States Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 4.4.1.1.1. Streptococcus 4.4.1.1.2. Legionella 4.4.1.1.3. Chlamydophila 4.4.1.1.4. Viral Pneumonia 4.4.1.1.5. Mycoplasma Pneumonia 4.4.1.2. United States Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 4.4.1.2.1. Molecular Diagnostics 4.4.1.2.2. Point of Care Testing 4.4.1.2.3. Immunodiagnostics 4.4.1.3. United States Pneumonia Testing Market Size and Forecast, by End- User (2023-2030) 4.4.1.3.1. 4.4.1.3.2. Hospitals & Clinics 4.4.1.3.3. Diagnostics Laboratories 4.4.1.3.4. Homecare 4.4.1.4. Canada 4.4.1.5. Canada Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 4.4.1.5.1. Streptococcus 4.4.1.5.2. Legionella 4.4.1.5.3. Chlamydophila 4.4.1.5.4. Viral Pneumonia 4.4.1.5.5. Mycoplasma Pneumonia 4.4.1.6. Canada Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 4.4.1.6.1. Molecular Diagnostics 4.4.1.6.2. Point of Care Testing 4.4.1.6.3. Immunodiagnostics 4.4.1.7. Canada Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 4.4.1.7.1. Hospitals & Clinics 4.4.1.7.2. Diagnostics Laboratories 4.4.1.7.3. Homecare 4.4.2. Mexico 4.4.2.1. Mexico Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 4.4.2.1.1. Streptococcus 4.4.2.1.2. Legionella 4.4.2.1.3. Chlamydophila 4.4.2.1.4. Viral Pneumonia 4.4.2.1.5. Mycoplasma Pneumonia 4.4.2.2. Mexico Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 4.4.2.2.1. Molecular Diagnostics 4.4.2.2.2. Point of Care Testing 4.4.2.2.3. Immunodiagnostics 4.4.2.3. Online Mexico Pneumonia Testing Market Size and Forecast, by End- User (2023-2030) 4.4.2.3.1. Hospitals & Clinics 4.4.2.3.2. Diagnostics Laboratories 4.4.2.3.3. Homecare 4.5. Europe Pneumonia Testing Market Size and Forecast by Segmentation (by Value in USD Billion) (2023-2030) 4.6. Europe Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 4.7. Europe Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 4.8. Europe Pneumonia Testing Market Size and Forecast, by End-Users (2023-2030) 4.9. Europe Pneumonia Testing Market Size and Forecast, by Country (2023-2030) 4.9.1. United Kingdom 4.9.1.1. United Kingdom Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 4.9.1.2. United Kingdom Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 4.9.1.3. United Kingdom Pneumonia Testing Market Size and Forecast, by End-Users (2023-2030) 4.9.2. France 4.9.2.1. France Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 4.9.2.2. France Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 4.9.2.3. France Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 4.9.3. Germany 4.9.3.1. Germany Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 4.9.3.2. Germany Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 4.9.3.3. Germany Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 4.9.4. Italy 4.9.4.1. Italy Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 4.9.4.2. Italy Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 4.9.4.3. Italy Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 4.9.5. Spain 4.9.5.1. Spain Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 4.9.5.2. Spain Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 4.9.5.3. Spain Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 4.9.6. Sweden 4.9.6.1. Sweden Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 4.9.6.2. Sweden Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 4.9.6.3. Sweden Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 4.9.7. Austria 4.9.7.1. Austria Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 4.9.7.2. Austria Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 4.9.7.3. Austria Pneumonia Testing Market Size and Forecast, by End- Users (2023-2030) 4.9.8. Rest of Europe 4.9.8.1. Rest of Europe Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 4.9.8.2. Rest of Europe Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 4.9.8.3. Rest of Europe Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 5. Asia Pacific Pneumonia Testing Market Size and Forecast by Segmentation (by Value in USD Billion) (2023-2030) 5.1. Asia Pacific Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 5.2. Asia Pacific Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 5.3. Asia Pacific Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 5.4. Asia Pacific Pneumonia Testing Market Size and Forecast, by Country (2023-2030) 5.5. China 5.5.1.1. China Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 5.5.1.2. China Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 5.5.1.3. China Pneumonia Testing Market Size and Forecast, by End-Users (2023-2030) 5.5.2. S Korea 5.5.2.1. S Korea Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 5.5.2.2. S Korea Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 5.5.2.3. S Korea Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 5.5.3. Japan 5.5.3.1. Japan Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 5.5.3.2. Japan Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 5.5.3.3. Japan Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 5.5.4. India 5.5.4.1. India Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 5.5.4.2. India Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 5.5.4.3. India Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 5.5.5. Australia 5.5.5.1. Australia Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 5.5.5.2. Australia Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 5.5.5.3. Australia Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 5.5.6. Indonesia 5.5.6.1. Indonesia Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 5.5.6.2. Indonesia Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 5.5.6.3. Indonesia Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 5.5.7. Malaysia 5.5.7.1. Malaysia Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 5.5.7.2. Malaysia Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 5.5.7.3. Malaysia Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 5.5.8. Vietnam 5.5.8.1. Vietnam Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 5.5.8.2. Vietnam Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 5.5.8.3. Vietnam Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 5.5.9. Taiwan 5.5.9.1. Taiwan Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 5.5.9.2. Taiwan Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 5.5.9.3. Taiwan Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 5.5.10. Rest of Asia Pacific 5.5.10.1. Rest of Asia Pacific Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 5.5.10.2. Rest of Asia Pacific Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 5.5.10.3. Rest of Asia Pacific Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 6. Middle East and Africa Pneumonia Testing Market Size and Forecast by Segmentation (by Value in USD Billion) (2023-2030) 6.1. Middle East and Africa Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 6.2. Middle East and Africa Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 6.3. Middle East and Africa Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 6.4. Middle East and Africa Pneumonia Testing Market Size and Forecast, by Country (2023-2030) 6.4.1. South Africa 6.4.1.1. South Africa Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 6.4.1.2. South Africa Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 6.4.1.3. South Africa Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 6.4.2. GCC 6.4.2.1. GCC Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 6.4.2.2. GCC Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 6.4.2.3. GCC Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 6.4.3. Nigeria 6.4.3.1. Nigeria Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 6.4.3.2. Nigeria Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 6.4.3.3. Nigeria Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 6.4.4. Rest of ME&A 6.4.4.1. Rest of ME&A Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 6.4.4.2. Rest of ME&A Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 6.4.4.3. Rest of ME&A Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 7. South America Pneumonia Testing Market Size and Forecast by Segmentation (by Value in USD Billion) (2023-2030 7.1. South America Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 7.2. South America Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 7.3. South America Pneumonia Testing Market Size and Forecast, by Country (2023-2030) 7.4. South America Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 7.4.1. Brazil 7.4.1.1. Brazil Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 7.4.1.2. Brazil Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 7.4.1.3. Brazil Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 7.4.2. Argentina 7.4.2.1. Argentina Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 7.4.2.2. Argentina Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 7.4.2.3. Argentina Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 7.4.3. Rest Of South America 7.4.3.1. Rest Of South America Pneumonia Testing Market Size and Forecast, by Type(2023-2030) 7.4.3.2. Rest Of South America Pneumonia Testing Market Size and Forecast, by Methods (2023-2030) 7.4.3.3. Rest Of South America Pneumonia Testing Market Size and Forecast, by End Users (2023-2030) 8. Global Pneumonia Testing Market: Competitive Landscape 8.1. MMR Competition Matrix 8.2. Competitive Landscape 8.3. Key Players Benchmarking 8.3.1. Company Name 8.3.2. Product Segment 8.3.3. End-user Segment 8.3.4. Revenue (2023) 8.3.5. Company Locations 8.4. Market Analysis by Organized Players vs. Unorganized Players 8.4.1. Organized Players 8.4.2. Unorganized Players 8.5. Leading Pneumonia Testing Market Companies, by market capitalization 8.6. Market Structure 8.6.1. Market Leaders 8.6.2. Market Followers 8.6.3. Emerging Players 8.7. Mergers and Acquisitions Details 9. Company Profile: Key Players 9.1. Thermo Fisher Scientific Inc. 9.1.1. Company Overview 9.1.2. Business Portfolio 9.1.3. Financial Overview 9.1.4. SWOT Analysis 9.1.5. Strategic Analysis 9.1.6. Scale of Operation (small, medium, and large) 9.1.7. Details on Partnership 9.1.8. Regulatory Accreditations and Certifications Received by Them 9.1.9. Awards Received by the Firm 9.1.10. Recent Developments 9.2. Abbott Laboratories 9.3. F-Hoffmann la Roche Ltd. 9.4. Hologic Inc. 9.5. BioMerieux 9.6. Becton 9.7. Dickenson and Company 9.8. Bio-Rad Laboratories Inc. 9.9. Meridian Biosciences 9.10. Quest Diagnostics, and Quidel. 9.11. AdvanDx 9.12. Beckman Coulter 9.13. Cepheid 9.14. Concile 9.15. Diamedix 9.16. DiaSorin 9.17. Fast-track Diagnostics 9.18. SeraCare 9.19. Trinity Biotech 10. Industry Recommendations 11. Pneumonia Testing Market: Research Methodology

About This Report

Report ID 112576
Category Healthcare
Published Date Feb 2024
Updated Date
  • INQUIRE BEFORE BUYING